AQP9 and fatty liver disease: Regarding liver AQP9, inhibition of AQP9-facilitated glycerol import by hepatocytes [31] may be effective in the prevention of liver steatosis and some of its severe consequences, such as steatohepatitis and cirrhosis [42], or in the control of gluconeogenesis from glycerol in T2D.